novel agents of interest for the treatment of bpdcn
Published 2 years ago • 85 plays • Length 2:12Download video MP4
Download video MP3
Similar videos
-
2:48
the safety and efficacy of tagraxofusp for the treatment of bpdcn
-
2:15
novel agents in trials for aml: quizartinib and gilteritinib
-
1:10
current standard of care in bpdcn
-
3:45
imgn632: a novel cd123 adc for r/r aml and bpdcn
-
3:18
blastic plasmacytoid dendritic cell neoplasms: current and future treatment options
-
40:36
a. krug - plasmacytoid dendritic cells between tolerance and immunity
-
10:41
blastic plasmacytoid dendritic cell neoplasm ( learn in 10 minutes)
-
15:41
nanoparticle-based contrast agents in biomedical imaging
-
27:36
novel therapies in myeloid neoplasms
-
2:58
itacitinib plus alemtuzumab for patients with t-pll
-
3:56
pathobiology & treatment of t-pll
-
1:04
horizon scan of novel and upcoming aml therapies
-
1:23
the challenge of relapse in transplant-eligible & transplant-ineligible patients with bdpcn
-
1:52
diving into multiple myeloma and other related diseases
-
21:27
novel investigational drugs in aml what's the data
-
10:23
rgenix cancer therapeutics company focuses on rna to identify novel targets
-
1:58
novel
-
12:01
novel marker fmd virus vaccine molecularly bound to nanoliprotein adjuvant - e. rieder
-
8:47
biotech company focused on the development and commercialisation of novel ivd tests